Testing the 'toxin hypothesis of allergy': Mast cells, IgE, and innate and acquired immune responses to venoms

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 80-87

  Tsai, Mindy ^a   Starkl, Philipp ^a   Marichal, Thomas ^b   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE A3; FC EPSILON RECEPTOR RI; FC RECEPTOR; HEPARIN; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG; VENOM; IMMUNOGLOBULIN E RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGY; CELL ACTIVATION; CELL ACTIVITY; CELL SURFACE; CELLULAR IMMUNITY; ENVENOMATION; HYPERSENSITIVITY; IMMUNOSTIMULATION; INNATE IMMUNITY; MAST CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; TH2 CELL; TOXIN ANALYSIS; ANIMAL; BLOOD; HUMAN; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY, INNATE; IMMUNOGLOBULIN E; MAST CELLS; RECEPTORS, IGE; VENOMS;

EID: 84937889749     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.07.001     Document Type: Review

References (49)

1. Akahoshi M., Song C.H., Piliponsky A.M., Metz M., Guzzetta A., Abrink M., Schlenner S.M., Feyerabend T.B., Rodewald H.R., Pejler G., et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest 2011, 121:4180-4191.
2. Higginbotham R.D., Karnella S. The significance of the mast cell response to bee venom. J Immunol 1971, 106:233-240.
3. Metz M., Grimbaldeston M.A., Nakae S., Piliponsky A.M., Tsai M., Galli S.J. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328.
4. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
5. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol Rev 1997, 77:1033-1079.
6. Saelinger C.B., Higginbotham R.D. Hypersensitivity responses to bee venom and the mellitin. Int Arch Allergy Appl Immunol 1974, 46:28-37.
7. Charavejasarn C.C., Reisman R.E., Arbesman C.E. Reactions of anti-bee venom mouse reagins and other antibodies with related antigens. Int Arch Allergy Appl Immunol 1975, 48:691-697.
8. Jarisch R., Yman L., Boltz A., Sandor I., Janitsch A. IgE antibodies to bee venom, phospholipase A, melittin and wasp venom. Clin Allergy 1979, 9:535-541.
9. Wadee A.A., Rabson A.R. Development of specific IgE antibodies after repeated exposure to snake venom. J Allergy Clin Immunol 1987, 80:695-698.
10. Annila I. Bee venom allergy. Clin Exp Allergy 2000, 30:1682-1687.
11. Reimers A.R., Weber M., Muller U.R. Are anaphylactic reactions to snake bites immunoglobulin E-mediated?. Clin Exp Allergy 2000, 30:276-282.
12. Bilo B.M., Rueff F., Mosbech H., Bonifazi F., Oude-Elberink J.N. Diagnosis of Hymenoptera venom allergy. Allergy 2005, 60:1339-1349.
13. Profet M. The function of allergy: immunological defense against toxins. Q Rev Biol 1991, 66:23-62.
14. Higginbotham R.D. Mast cells and local resistance to Russell's viper venom. J Immunol 1965, 95:867-875.
15. Wernersson S., Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol 2014, 14:478-494.
16. Schneider L.A., Schlenner S.M., Feyerabend T.B., Wunderlin M., Rodewald H.R. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007, 204:2629-2639.
17. Marichal T., Starkl P., Reber L.L., Kalesnikoff J., Oettgen H.C., Tsai M., Metz M., Galli S.J. A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013, 39:963-975.
18. fl/fl mice. Blood 2011, 118:6930-6938.
19. Maurer M., Wedemeyer J., Metz M., Piliponsky A.M., Weller K., Chatterjea D., Clouthier D.E., Yanagisawa M.M., Tsai M., Galli S.J. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004, 432:512-516.
20. Fry B.G. From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res 2005, 15:403-420.
21. Couvineau A., Laburthe M. VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. Br J Pharmacol 2012, 166:42-50.
22. Fry B.G., Roelants K., Champagne D.E., Scheib H., Tyndall J.D., King G.F., Nevalainen T.J., Norman J.A., Lewis R.J., Norton R.S., et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 2009, 10:483-511.
23. Kuhn-Nentwig L. Antimicrobial and cytolytic peptides of venomous arthropods. Cell Mol Life Sci 2003, 60:2651-2668.
24. Palm N.W., Medzhitov R. Role of the inflammasome in defense against venoms. Proc Natl Acad Sci U S A 2013, 110:1809-1814.
25. Schäfer B., Piliponsky A.M., Oka T., Song C.H., Gerard N.P., Gerard C., Tsai M., Kalesnikoff J., Galli S.J. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J Allergy Clin Immunol 2013, 131:541-548.
26. Tambourgi D.V., van den Berg C.W. Animal venoms/toxins and the complement system. Mol Immunol 2014, 61:153-162.
27. Paul W.E., Zhu J. How are T(H)2-type immune responses initiated and amplified?. Nat Rev Immunol 2010, 10:225-235.
28. Galli S.J., Tsai M. IgE and mast cells in allergic disease. Nat Med 2012, 18:693-704.
29. Pulendran B., Artis D. New paradigms in type 2 immunity. Science 2012, 337:431-435.
30. Holgate S.T., Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008, 8:218-230.
31. Artis D., Maizels R.M., Finkelman F.D. Forum: Immunology: Allergy challenged. Nature 2012, 484:458-459.
32. Portier M.M., Richet C. De l'action anaphylactique de certains venims. C R Soc Biol 1902, 54:170-172.
33. Finkelman F.D. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007, 120:506-515. quiz 516-507.
34. Finkelman F.D., Shea-Donohue T., Morris S.C., Gildea L., Strait R., Madden K.B., Schopf L., Urban J.F. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004, 201:139-155.
35. Stetson D.B., Voehringer D., Grogan J.L., Xu M., Reinhardt R.L., Scheu S., Kelly B.L., Locksley R.M. Th2 cells: orchestrating barrier immunity. Adv Immunol 2004, 83:163-189.
36. Fitzsimmons C.M., Dunne D.W. Survival of the fittest: allergology or parasitology?. Trends Parasitol 2009, 25:447-451.
37. Stebbings J.H. Immediate hypersensitivity: a defense against arthropods?. Perspect Biol Med 1974, 17:233-239.
38. Palm N.W., Rosenstein R.K., Medzhitov R. Allergic host defences. Nature 2012, 484:465-472.
39. Palm N.W., Rosenstein R.K., Yu S., Schenten D.D., Florsheim E., Medzhitov R. Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013, 39:976-985.
40. Habermann E. Bee and wasp venoms. Science 1972, 177:314-322.
41. Dudler T., Machado D.C., Kolbe L., Annand R.R., Rhodes N., Gelb M.H., Koelsch K., Suter M., Helm B.A. A link between catalytic activity. IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2. J Immunol 1995, 155:2605-2613.
42. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999, 17:931-972.
43. Oettgen H.C., Geha R.S. IgE in asthma and atopy: cellular and molecular connections. J Clin Invest 1999, 104:829-835.
44. Rivera J., Fierro N.A., Olivera A., Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 2008, 98:85-120.
45. Antonicelli L., Bilo M.B., Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol 2002, 2:341-346.
46. Akdis C.A., Akdis M. Advances in allergen immunotherapy: Aiming for complete tolerance to allergens. Sci Transl Med 2015, 7:280ps286.
47. Muller U.R. Bee venom allergy in beekeepers and their family members. Curr Opin Allergy Clin Immunol 2005, 5:343-347.
48. Meiler F., Zumkehr J., Klunker S., Ruckert B., Akdis C.A., Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008, 205:2887-2898.
49. Ozdemir C., Kucuksezer U.C., Akdis M., Akdis C.A. Mechanisms of immunotherapy to wasp and bee venom. Clin Exp Allergy 2011, 41:1226-1234.